Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorJessa Hospital
About this trial
This study aims to investigate the effectiveness of photobiomodulation therapy (PBMT) in the prevention and management of radiotherapy-induced vaginal toxicity (RIVT). Therefore, we hypothesize that PBMT can reduce the severity of RIVT in gynecological cancer patients, increasing the patient's QoL and sexual functioning.
Eligibility criteria
Qualifiers
Diagnosed with endometrial cancer
Scheduled for external beam radiotherapy (EBRT), intracavitary brachytherapy (BT), or a combination
Age ≥ 18 years
Able to comply to the study protocol
Disqualifiers
Metastatic disease
Pregnancy
Diagnosis of vaginal stenosis before radiotherapy (RT)
Previous pelvic tumor or pelvic RT
Trial design
Treatments tested in this trial
- Intimleds
Treatment groups
62 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov